Hung David 4

What Happened David Hung, a director of NovoCure Ltd (NVCR), disposed of 2,945 shares on 2026-06-02 in an open-market sale. The weighted-average sale price was $15.77, for total proceeds of approximately $46,445. This was a sale (not a purchase) and was executed to satisfy tax withholding obligations related to vested restricted stock units — a non-discretionary, issuer-mandated "sell-to-cover" action.

Key Details

• Transaction date: 2026-06-02 (reported on Form 4 filed 2026-06-03) — filing appears timely.
• Shares sold: 2,945; weighted-average price: $15.77; total proceeds ≈ $46,445.
• Price range: executed in multiple trades between $15.65 and $15.88 (weighted avg reported).
• Reason/footnote: Sale mandated to cover tax withholding on RSU vesting (sell-to-cover), not a discretionary trade by the reporting person.
• Shares owned after transaction: not specified in the provided data.

Context Sell-to-cover transactions are common when restricted stock units vest and do not necessarily signal an insider view on the company's prospects. This Form 4 reports a routine tax-withholding sale rather than a voluntary investment decision.